SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089549
Filing Date
2023-08-10
Accepted
2023-08-10 07:09:03
Documents
15
Period of Report
2023-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323293d1_8k.htm   iXBRL 8-K 29096
2 EXHIBIT 99.1 tm2323293d1_ex99-1.htm EX-99.1 9114
6 GRAPHIC tm2323293d1_ex99-1img001.jpg GRAPHIC 3939
7 GRAPHIC tm2323293d1_ex99-1img002.jpg GRAPHIC 41506
  Complete submission text file 0001104659-23-089549.txt   280195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA trda-20230804.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20230804_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20230804_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2323293d1_8k_htm.xml XML 3423
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 231157156
SIC: 2834 Pharmaceutical Preparations